The global computer vision in healthcare market size was valued at USD 3.80 billion in 2025 and is projected to grow from USD 4.51 billion in 2026 to USD 17.59 billion by 2034, registering a CAGR of 18.56% during the forecast period (2026–2034). North America dominated the computer vision in healthcare market with a share of 36.44% in 2025.
Computer vision in healthcare refers to AI-based technologies that analyze and interpret medical images, video, and other visual data to support clinical assessment and healthcare workflows. Applications include medical image analysis, disease detection, image-guided procedures, patient monitoring, and computer-aided diagnosis. Computer vision in healthcare solutions are tracked under HSN Code 8523 (recording media, including software) and SIC Code 7372 (prepackaged software).
The computer vision in healthcare market demand is driven by the use of AI in medical imaging, the need for faster diagnostic analysis, and the adoption of automated clinical decision support technologies. Healthcare providers are using computer vision for image analysis, lesion detection, disease identification, and patient monitoring, contributing to computer vision in healthcare market growth.
By Component
By Product
By Application
By End User
Download a Free Sample To learn more about this report,
Integration of Multimodal Medical Image Analysis
Computer vision and artificial intelligence (AI) are being combined with clinical data to support more comprehensive medical image analysis. Deep learning and machine learning (ML) can help assess imaging findings alongside patient information for computer-aided diagnosis (CAD) and clinical decision support. This integration improves the depth of information available for healthcare assessment.
Development of Computer Vision for Surgical Guidance
Computer vision in healthcare market analysis shows that it is being applied during surgical procedures to recognize anatomy, instruments, and procedural details in real time. Image recognition and object detection can help provide visual guidance and support more precise actions during complex procedures. This development strengthens healthcare automation and computer-assisted surgery.
Supply chain disruptions are expected to have a moderate impact on computer vision in healthcare market share, as dependence on GPUs, high-bandwidth memory, imaging hardware, and specialized processing components can increase technology costs and delay system deployments. The market is likely to follow a J-shaped recovery pattern, as implementation of computer vision systems can slow during periods of constrained computing capacity but accelerate once hardware and cloud resources become available. The market is expected to grow at a CAGR of 18.56%, but supply chain constraints could approximately lower this by 0.4 percentage points, resulting in short-term growth of around 18.16%. As supply conditions normalize through improved AI hardware availability, expanded cloud capacity, diversified technology suppliers, and more reliable computing infrastructure, computer vision in healthcare market growth is expected to accelerate and gradually recover.
The computer vision in healthcare market forecasts investments directed toward AI-powered medical imaging, automated diagnostic screening, radiology platforms, and computer-vision-based clinical tools to improve early disease detection and expand access to diagnostic services.
Key Investment and Funding Activities in Computer Vision in Healthcare Market, 2026
CARPL.ai
USD 10 million in Series A funding
In July 2026, CARPL.ai raised USD 10 million in Series A funding led by IFC to accelerate adoption of AI in medical imaging. Its platform enables healthcare providers to evaluate, integrate, and monitor radiology AI applications, supporting the deployment of computer-vision technologies across clinical imaging workflows.
Aidoc
USD 150 million in Series E funding
In April 2026, Aidoc raised USD 150 million in Series E funding to expand its AI-powered medical imaging platform, which analyzes CT scans and X-rays to detect and prioritize clinical findings. The funding supports expansion of its clinical AI solutions across healthcare systems and strengthens investment in computer-vision-based medical imaging.
High Medical Imaging Workload Growth and Radiologist Shortages Drive Market Demand
Higher volumes of X-rays, CT scans, MRI studies, ultrasound examinations, and other medical imaging procedures are increasing the amount of visual data that radiology departments must review. Large image workloads can place pressure on reporting capacity and increase the need for efficient image-analysis workflows. Computer vision can support image recognition, abnormality detection, and case prioritization across these large datasets.
Shortages of radiologists and other imaging specialists can limit the capacity of healthcare facilities to review expanding diagnostic image volumes. Radiology AI and computer-aided diagnosis (CAD) tools can assist with image screening and workflow prioritization while keeping final clinical decisions with specialists. This support can help imaging departments manage constrained expert capacity more effectively.
Imaging Protocol Variability and Annotation Requirements Restrain Market Expansion
Variations in medical imaging protocols across scanners, acquisition settings, image resolutions, and healthcare facilities can affect the consistency of computer vision model outputs. Differences in image characteristics can reduce the transferability of models trained on specific datasets and complicate deployment across diverse clinical environments. This variability can affect the performance of deep learning, machine learning (ML), and image recognition systems.
High annotation requirements can increase the resources needed to develop and validate healthcare computer vision models. Accurate labeling of radiology and pathology images often requires review by qualified specialists to identify disease patterns, anatomical structures, or other features for object detection and automated analysis. Greater annotation complexity can therefore constrain the development of advanced AI solutions for healthcare.
Pathology Imaging Development and Rehabilitation Monitoring Create Market Growth Opportunities
The development of pathology imaging solutions can enable computer vision systems to analyze digitized tissue slides for cellular structures, tissue patterns, and morphological abnormalities. The integration of deep learning, image recognition, and object detection can assist pathologists with slide review and classification tasks. This creates opportunities for technology providers to develop specialized clinical image-analysis solutions.
Computer vision development for rehabilitation monitoring can enable automated assessment of patient movement, posture, and exercise performance during physical therapy. Object detection and visual motion analysis generate measurable information on movement quality and rehabilitation progress. Healthcare providers can incorporate these capabilities into supervised or remote rehabilitation programs without requiring continuous manual observation.
Imaging Dataset Shifts and Complex Clinical Accountability Risks Challenge Market Growth
Dataset drift across changing clinical data can reduce the performance of computer vision systems when patient populations, disease characteristics, or clinical datasets change over time. Algorithms trained on historical datasets may require ongoing monitoring, recalibration, and retraining to maintain reliable outputs. These maintenance requirements can complicate the long-term deployment of deep learning, machine learning (ML), and automated diagnosis solutions.
Unclear clinical accountability for AI-supported outputs can create challenges when computer vision contributes to clinical decision support or automated diagnostic assessments. Healthcare institutions may need clearly defined responsibility for reviewing AI-generated findings, addressing incorrect outputs, and making final clinical decisions. Ambiguity around these responsibilities can increase caution among providers considering AI-assisted workflows.
The hardware segment accounted for a share of 34.28% in 2025, supported by the need for cameras, imaging sensors, and computing units for medical image capture and analysis.
The software cloud-based segment accounted for a share of 21.36% in 2025, driven by adoption of cloud platforms for storing and analyzing medical images. Cloud-based systems enable centralized deployment of computer vision applications.
Request Customizationto receive a tailored report.
The smart camera-based computer vision system segment is expected to grow at a CAGR of 19.21% during the forecast period, supported by cameras with integrated image capture and AI-based analysis. These systems enable real-time visual detection and monitoring.
The PC-based computer vision systems segment is expected to grow at a CAGR of 18.04% during the forecast period, fueled by PC-based processing of medical images and visual data.
The medical imaging & diagnostics segment accounted for a share of 32.84% in 2025, supported by computer vision applications for analyzing X-rays, CT scans, MRI scans, and other medical images.
The drug discovery segment is expected to grow at a CAGR of 20.14% during the forecast period, propelled by computer vision for analyzing cells, tissues, and laboratory images. Automated visual analysis supports drug screening and research activities.
The healthcare providers segment accounted for a share of 46.72% in 2025, owing to computer vision use in radiology, pathology, surgery, and clinical monitoring. These systems assist with image analysis and diagnostic assessment.
The pharmaceutical & biotechnology companies segment is expected to grow a CAGR of 20.07% during the forecast period, driven by computer vision applications in drug screening and laboratory research.
Speak to an Analystto discuss market opportunities.
Market Dominance Led by Acceptance of Healthcare Analytics
North American computer vision in healthcare market accounted for the largest regional share of 36.44% in 2025, supported by expanding computer-aided diagnosis (CAD), healthcare analytics, and AI applications across medical imaging.
The U.S. computer vision in healthcare market benefits from increasing integration of AI-based image analysis into radiology and other diagnostic workflows. The FDA’s AI-enabled medical device list recorded clearances for Auto-Seg Spine, Auto-Seg, ADAS 3D, MammoScreen, and Syngo. CT Coronary Cockpit and GE Enhanced Boundary for PCCT, among other imaging-related systems, strengthening the U.S. landscape for AI-enabled computer vision applications.
Canada’s computer vision in healthcare market is supported by growing use of medical image interpretation and automated image segmentation in diagnostic care. Health Canada issued pre-market guidance for machine learning-enabled medical devices, covering AI systems that acquire, process, and analyze medical images and supporting their regulated use in diagnostic imaging.
Unlock Regional Insightsto access country-level data, & regional trends.
Fastest Growth Driven by Adoption of Cloud-based Imaging Software and AI-Assisted Surgery
The Asia Pacific computer vision in healthcare market is expected to grow at a CAGR of 20.38% during the forecast period, supported by increasing adoption of cloud-based software, smart camera-based computer vision systems, pathology imaging, and AI-assisted surgical technologies.
Japan’s market is supported by wider adoption of digital pathology imaging and automated slide analysis. In June 2026, the University of Toyama issued a public procurement notice for a digital pathology system with AI-assisted image analysis and virtual-slide capabilities, expanding institutional use of computer vision in pathology.
China’s computer vision in healthcare market is gaining from the deployment of smart camera-based visual systems across healthcare settings. China's National Health Commission directed hospitals to expand AI applications, including intelligent medical-imaging analysis and monitoring systems, within healthcare facilities.
The India computer vision in healthcare market benefits from the use of AI-assisted surgical technologies and medical image analysis in government hospitals. IndiaAI and the National Cancer Grid launched the CATCH Grant Program, supporting AI solutions for cancer screening and diagnosis, including medical image analysis applications.
Market Growth Supported by Use of On-Premise Imaging Software and Strong Research Base
The Europe computer vision in healthcare market is expected to grow at a CAGR of 7.89% during the forecast period, supported by adoption of on-premise imaging software, academic research applications, and computer-vision tools for drug discovery.
The UK market is supported by the use of on-premise software for controlled medical-image processing within healthcare and research environments. In 2025, the UK National Institute for Health and Care Research (NIHR) funded AI-focused research programs examining image-based technologies for clinical applications, supporting continued development of advanced healthcare imaging systems.
Germany's computer vision in healthcare market is boosted by strong activity among academic research institutes applying computer vision to pharmaceutical and biomedical research. The German Research Foundation (DFG) funded interdisciplinary research involving AI and biomedical image analysis, supporting the use of computer-vision methods in drug discovery and preclinical research.
Market Expansion Led by Focus on Diagnostic Imaging Automation and Clinical Decision Support
The Latin America computer vision in healthcare market is expected to grow at a CAGR of 16.31% during the forecast period, led by increasing adoption among healthcare providers and diagnostic centers, alongside growing use of clinical decision support and healthcare automation. In January 2026, Mexico began construction of a high-specialty imaging center in Tlalpan designed to receive and analyze medical images remotely. In Brazil, researchers at the Federal University of Campina Grande are developing deep learning methods for automated medical image analysis, covering disease detection, segmentation, and classification.
Market Shaped by Adoption of Radiology AI and Digital Medical Image Analysis
The Middle East & Africa computer vision in healthcare market is expected to grow at a CAGR of 15.87% during the forecast period. The Emirates Health Services in the UAE focuses on a radiology modernization plan that includes expanded AI integration into medical imaging and redesigned radiology workflows. In South Africa, the National Health Laboratory Service launched AI-driven pathology research to automate analysis of bone-marrow plasma-cell burden, supporting computer-vision use in diagnostic image interpretation.
The computer vision in healthcare market competitive landscape is moderately concentrated, with participation from global semiconductor and computing companies, artificial intelligence developers, medical-imaging technology firms, and specialized healthcare computer-vision solution providers. Key players such as NVIDIA Corporation, Microsoft Corporation, Intel Corporation, IBM Corporation, and Voxel51 are collectively estimated to account for approximately 30–35% of the global computer vision in healthcare market share.
Established participants compete primarily through AI and GPU computing capabilities, image processing performance, healthcare data integration, and cybersecurity. Emerging, niche, and regional companies in the computer vision in healthcare market ecosystem compete through computer-aided diagnosis, surgical guidance, customized workflows, and cost-efficient solutions tailored to individual healthcare settings.
May 2026: The American College of Radiology approved its first practice parameter for imaging AI and introduced the Assess-AI framework for monitoring AI performance and quality in clinical imaging.
April 2026: GE HealthCare received FDA 510(k) clearance for True Definition DL, a deep-learning solution designed to improve CT spatial resolution and suppress image artifacts while supporting faster imaging workflows.
March 2026: GE HealthCare acquired Intelerad, expanding its enterprise imaging software capabilities across hospitals, ambulatory settings, and teleradiology.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Medical Kiosk Market Size, Share, Growth, Analysis, Report, 2034
Reusable Insulin Injector Pens Market Size, Share, 2034
Laboratory Informatics Market Size, Share, Growth, Analysis, 2034
Fitness App Market Size, Share, Growth, Analysis, Report, 2034
Operating Room Integration Market Size, Share, Growth, 2034
Healthcare Artificial Intelligence (AI) Market Size, Share, Report, 2034
We are featured on:
sales@straitsresearch.com